Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
554.00    0.00 (0.00%)
Bid:
554.50
Ask:
555.00
Spread: 0.50 (0.09%)
Market Cap: £2.45b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

22 Apr 2024 14:30

RNS Number : 5523L
Tate & Lyle PLC
22 April 2024
Β 

Β 

Tate & Lyle PLC

Β 

Notification of transactions by Persons Discharging Managerial Responsibilities

Β 

Tate & Lyle PLC (the 'Company') announces that ordinary shares of 29 1/6 pence each in the capital of the Company ('Shares') were released on 18 April 2024 to Bill Magee and Melissa Law, Persons Discharging Managerial Responsibilities.

Β 

This release of 6,980 Shares to Bill Magee and 5,028 Shares to Melissa Law corrects the withholding of tax applied to the release of Shares to Bill and Melissa on 2 April 2024 pursuant to the vesting of their Restricted Share Awards (announced on 4 April 2024, RNS Number: 3412J). For tax purposes, the market value of the Shares remains 608.5 pence per Share. No consideration was paid for the acquisition of these Shares.

Β 

A summary table of the number of Shares issued to correct the withholding of tax on the awards is below:

Β 

Β 

Column A

Column B

Column C

Column D

Column E

PDMR

Number of Shares subject to RSA

Initial number of Shares withheld to satisfy tax obligations

Total number of Shares that should have been withheld to satisfy tax obligations

Additional Shares released on 18 April 2024 to correct over-withholding (Column B)

Β 

(Column B minus Column C)

Total (corrected) number of Shares retained from RSA

Β 

(Column A minus Column C)

Bill Magee

33,739

19,762

12,782

6,980

20,957

Melissa Law

103,813

43,424

38,396

5,028

65,417

Β 

The notifications below, which have been made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail.

Β 

Claire-Marie O'Grady

Company Secretary

22 April 2024

Β 

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Bill Magee

2.

Reason for the notification

a)

Position / status

President, North America

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

Β 

GB00BP92CJ43

b)

Nature of the transaction

Additional release of shares (acquisition by the PDMR) due to over-withholding of tax on release of RSA award on 2 April 2024.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

6,980

d)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

6,980

Β 

Nil

e)

Date of the transaction

2024-04-18

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Melissa Law

2.

Reason for the notification

a)

Position / status

President, Global Operations

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

Β 

GB00BP92CJ43

b)

Nature of the transaction

Additional release of shares (acquisition by the PDMR) due to over-withholding of tax on release of RSA award on 2 April 2024.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

5,028

d)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

5,028

Β 

Nil

e)

Date of the transaction

2024-04-18

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUUAORSAUSUAR
Date   Source Headline
23rd Jun 20223:00 pmRNSHolding(s) in Company
21st Jun 20222:30 pmRNSAnnual Financial Report and Notice of Meeting 2022
17th Jun 20222:00 pmRNSHolding(s) in Company
15th Jun 20222:00 pmRNSHolding(s) in Company
15th Jun 20227:00 amRNSProposed Cancellation&Repayment Preference Shares
10th Jun 20222:00 pmRNSHolding(s) in Company
9th Jun 20227:06 amRNSAcquisition
9th Jun 20227:00 amRNSFinal Results
19th May 20225:00 pmRNSDirector/PDMR Shareholding
9th May 20222:23 pmRNSHolding(s) in Company
6th May 20222:46 pmRNSHolding(s) in Company
3rd May 20225:45 pmRNSHolding(s) in Company
3rd May 20228:01 amRNSShare Consolidation Effective Total Voting Rights
29th Apr 20223:15 pmRNSListing and Trading Application
26th Apr 20224:00 pmRNSResult of Meeting
13th Apr 20222:00 pmRNSHolding(s) in Company
7th Apr 20225:30 pmRNSHolding(s) in Company
7th Apr 202211:00 amRNSCirc re. special dividend and share consolidation
5th Apr 20224:00 pmRNSHolding(s) in Company
4th Apr 20224:00 pmRNSDirector/PDMR Shareholding
1st Apr 20222:15 pmRNSDisposal completion
1st Apr 20222:00 pmRNSTotal Voting Rights
31st Mar 20227:00 amRNSAcquisition
24th Mar 20222:00 pmRNSHolding(s) in Company
24th Mar 202211:00 amRNSDirectorate Change
21st Mar 20222:00 pmRNSHolding(s) in Company
18th Mar 20223:30 pmRNSHolding(s) in Company
10th Mar 20222:00 pmRNSHolding(s) in Company
9th Mar 20222:00 pmRNSHolding(s) in Company
1st Mar 20229:22 amRNSTotal Voting Rights
18th Feb 20222:00 pmRNSHolding(s) in Company
17th Feb 20222:00 pmRNSHolding(s) in Company
14th Feb 20222:00 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSTrading Statement
10th Feb 20222:00 pmRNSHolding(s) in Company
9th Feb 20227:00 amRNSDirectorate Change
3rd Feb 20224:00 pmRNSHolding(s) in Company
1st Feb 20223:30 pmRNSHolding(s) in Company
21st Jan 20222:00 pmRNSHolding(s) in Company
17th Jan 20222:00 pmRNSHolding(s) in Company
12th Jan 20224:00 pmRNSHolding(s) in Company
10th Jan 20223:45 pmRNSChange of Registered Office
10th Jan 20223:40 pmRNSDirector/PDMR Shareholding
4th Jan 20224:00 pmRNSBlock listing Interim Review
10th Dec 20212:09 pmRNSHolding(s) in Company
9th Dec 20213:10 pmRNSDirector/PDMR Shareholding
1st Dec 20219:58 amRNSTotal Voting Rights
18th Nov 20214:15 pmRNSHolding(s) in Company
5th Nov 202111:45 amRNSDirector/PDMR Shareholding
4th Nov 20217:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.